| HGNC Family | Non-coding RNAs |
| Name | microRNA 885 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nResearch over the past decade has revealed that members of the miR‐885 family—including miR‐885‐5p and miR‐885‐3p—play multifaceted, context‐dependent roles in cancer biology. In neuroblastoma, for example, ectopic expression of miR‐885‐5p induces cell cycle arrest, senescence, and apoptosis via p53 pathway activation and by targeting cell cycle regulators such as cyclin‐dependent kinase 2 (CDK2) and mini‐chromosome maintenance protein 5 (MCM5) ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "]. In squamous cell carcinoma, a cisplatin‐induced isoform—miR‐885‐3p—plays a key role in modulating apoptosis by regulating transcripts encoding proteins such as MDM4, BCL2, and several caspases ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "]. Genetic variation that impairs miR‐885‐5p binding to targets like CASP3 further supports its importance in tumor suppression ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "]. However, miR‐885’s functions are not uniformly suppressive. In colorectal cancer, elevated levels of miR‐885‐5p have been linked with enhanced cell migration, invasion, and epithelial–mesenchymal transition via repression of factors that normally restrain TWIST1 expression ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "], whereas in hepatocellular carcinoma, overexpression of miR‐885‐5p is associated with decreased metastasis through downregulation of CTNNB1 and consequent inhibition of Wnt/β‐catenin signaling ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "]. In gastric cancer, miR‐885‐3p acts as a tumor suppressor by inhibiting cyclin‐dependent kinase 4 (CDK4); notably, its activity is counteracted by oncogenic long noncoding RNAs that “sponge” miR‐885‐3p, thereby facilitating cell proliferation ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "]. In chemoresistant lung adenocarcinoma, reduced miR‐885‐5p leads to increased Aurora A kinase expression and diminished drug sensitivity ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "], while in cancer stem‐like cells, attenuation of miR‐885‐5p results in augmented insulin‐like growth factor 1 receptor (IGF1R) expression that supports stemness and chemoresistance ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "]. Moreover, by targeting BMPR1A and thereby impairing Smad/Id1 signaling, miR‐885‐3p suppresses angiogenesis in colon cancer models ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "]. Paradoxically, in certain liver tumors, miR‐885‐5p appears to promote tumorigenesis via upregulation of TIGAR through chromatin modification ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "], and deregulation of miR‐885 activity through competing endogenous RNA (ceRNA) mechanisms is emerging as an important factor in breast and thyroid cancers ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "].\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond oncogenesis, miR‐885 exerts significant influence in nonmalignant diseases by modulating inflammation, cellular injury, and metabolic processes. In metabolic liver disorders and during acute hepatitis C virus infection, altered circulating levels of miR‐885‐5p correlate with fatty liver development and changes in lipoprotein metabolism—possibly through regulation of lipid receptors such as oxysterol‐binding protein–like 2 (OSBPL2) ["}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "16"}]}, {"type": "t", "text": "]. Cardioprotective roles for miR‐885‐5p have been identified in cardiomyocytes exposed to hypoxia/reoxygenation, where its upregulation attenuates apoptosis via suppression of pro‐apoptotic mediators such as PTEN and BCL2L11 and by enhancing AKT/mTOR signaling ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": "]. In immune‐mediated conditions, including asthma and cutaneous lupus erythematosus, miR‐885 regulates key receptors—such as the vitamin D receptor (VDR) and toll‐like receptor 4 (TLR4)—to dampen pro‐inflammatory NF‐κB and MyD88 signaling; genetic variants that affect its binding can thereby exacerbate disease severity ["}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "21"}]}, {"type": "t", "text": "]. Altered miR‐885 expression has also been documented in pre‐eclampsia, osteoarthritis, and cystic fibrosis, highlighting its promise as a circulating biomarker in diverse pathological states ["}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "22", "end_ref": "24"}]}, {"type": "t", "text": "]. In addition, miR‐885 participates in cellular differentiation—for instance, by post‐transcriptionally regulating dentin sialophosphoprotein (DSPP) during odontoblast maturation ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "25"}]}, {"type": "t", "text": "]—and modulates monocyte inflammatory responses in type 1 diabetes ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "26"}]}, {"type": "t", "text": "]. Epigenetic studies also indicate that changes in miR‐885 are linked with successful cognitive aging ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "27"}]}, {"type": "t", "text": "]. Finally, emerging data in prostate and ovarian cancers suggest that ceRNA networks involving long noncoding RNAs and circular RNAs can sequester miR‐885, thereby further influencing its regulatory capacity and underscoring its potential as a therapeutic target ["}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "28", "end_ref": "30"}]}, {"type": "t", "text": "].\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "E A Afanasyeva, P Mestdagh, C Kumps, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cdd.2010.164"}], "href": "https://doi.org/10.1038/cdd.2010.164"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21233845"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21233845"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yiping Huang, Alice Y Chuang, Edward A Ratovitski "}, {"type": "b", "children": [{"type": "t", "text": "Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.10.22.18107"}], "href": "https://doi.org/10.4161/cc.10.22.18107"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22071691"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22071691"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xiaoxiang Guan, Zhensheng Liu, Hongliang Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.12-223420"}], "href": "https://doi.org/10.1096/fj.12-223420"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23271051"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23271051"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Colin Siu-Chi Lam, Lui Ng, Ariel Ka-Man Chow, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of microRNA 885-5p as a novel regulator of tumor metastasis by targeting CPEB2 in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.15844"}], "href": "https://doi.org/10.18632/oncotarget.15844"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28460469"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28460469"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Zhuhong Zhang, Jing Yin, Jian Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/β-catenin signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.12602"}], "href": "https://doi.org/10.18632/oncotarget.12602"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27738331"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27738331"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Zhijuan Lin, Zhixia Zhou, Hang Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA gastric cancer-related lncRNA1 mediates gastric malignancy through miRNA-885-3p and cyclin-dependent kinase 4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-018-0643-5"}], "href": "https://doi.org/10.1038/s41419-018-0643-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29789536"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29789536"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Zhaoyu Jiang, Huaiping Cui, Shujie Zeng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-885-5p Inhibits Invasion and Metastasis in Gastric Cancer by Targeting Malic Enzyme 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "DNA Cell Biol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/dna.2020.6478"}], "href": "https://doi.org/10.1089/dna.2020.6478"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33751897"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33751897"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Jiongrui Cao, Jian Geng, Xiaoyuan Chu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA‑885‑3p inhibits docetaxel chemoresistance in lung adenocarcinoma by downregulating Aurora A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2018.6858"}], "href": "https://doi.org/10.3892/or.2018.6858"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30431113"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30431113"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Claudia Meier, Philip Hardtstock, Sophie Joost, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem-like Features via miR-885-5p Control."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-15-1228"}], "href": "https://doi.org/10.1158/0008-5472.CAN-15-1228"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26554827"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26554827"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "F Xiao, H Qiu, H Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-885-3p inhibits the growth of HT-29 colon cancer cell xenografts by disrupting angiogenesis via targeting BMPR1A and blocking BMP/Smad/Id1 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.134"}], "href": "https://doi.org/10.1038/onc.2014.134"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24882581"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24882581"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Shubiao Zou, Yao Rao, Weicai Chen "}, {"type": "b", "children": [{"type": "t", "text": "miR-885-5p plays an accomplice role in liver cancer by instigating TIGAR expression via targeting its promoter."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biotechnol Appl Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/bab.1767"}], "href": "https://doi.org/10.1002/bab.1767"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31119791"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31119791"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Xiqian Zhou, Wei Jian, Qifeng Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA_0006014 promotes breast cancer progression through sponging miR-885-3p to regulate NTRK2 and PIK3/AKT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.203996"}], "href": "https://doi.org/10.18632/aging.203996"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35383130"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35383130"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Jessica Gambardella, Urna Kansakar, Celestino Sardu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pharmacol Exp Ther (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/jpet.122.001209"}], "href": "https://doi.org/10.1124/jpet.122.001209"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35772782"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35772782"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Christian Beyer, Anna Zampetaki, Neng-Yu Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Signature of circulating microRNAs in osteoarthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Rheum Dis (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/annrheumdis-2013-204698"}], "href": "https://doi.org/10.1136/annrheumdis-2013-204698"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24515954"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24515954"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Ramy El-Diwany, Lisa N Wasilewski, Kenneth W Witwer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.00955-15"}], "href": "https://doi.org/10.1128/JVI.00955-15"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26157120"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26157120"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Emma Raitoharju, Ilkka Seppälä, Leo-Pekka Lyytikäinen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism-The Young Finns Study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep38262"}], "href": "https://doi.org/10.1038/srep38262"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27917915"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27917915"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Xin Meng, Lijun Mei, Chedong Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-885 mediated cardioprotection against hypoxia/reoxygenation-induced apoptosis in human cardiomyocytes via inhibition of PTEN and BCL2L11 and modulation of AKT/mTOR signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.29460"}], "href": "https://doi.org/10.1002/jcp.29460"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31960416"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31960416"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Xia Ji, Jinbao Mao, Shuang Zhou "}, {"type": "b", "children": [{"type": "t", "text": "Rs739837 Polymorphism in MiR-885-3p Binding Site Within 3'-Untranslated Region of Vitamin D Receptor is Associated with a Decreased Risk of Pressure Ulcers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000485952"}], "href": "https://doi.org/10.1159/000485952"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29241179"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29241179"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Guan-Shan Yang, Wei Hou, Jing-Lin Ou "}, {"type": "b", "children": [{"type": "t", "text": "Rs739837 affects the severity of asthma by disrupting the binding of microRNA-885."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Per Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/pme-2019-0026"}], "href": "https://doi.org/10.2217/pme-2019-0026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32157950"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32157950"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Yahui Shen, Aigui Jiang, Rong Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-885-3p alleviates bronchial epithelial cell injury induced by lipopolysaccharide via toll-like receptor 4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2022.2032939"}], "href": "https://doi.org/10.1080/21655979.2022.2032939"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35156897"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35156897"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Cristina Solé, Sandra Domingo, Eleonora Penzo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of miR-885-5p Promotes NF-κB Pathway Activation and Immune Recruitment in Cutaneous Lupus Erythematosus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jid.2022.08.036"}], "href": "https://doi.org/10.1016/j.jid.2022.08.036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36049539"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36049539"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "V C Sandrim, M R Luizon, A C Palei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating microRNA expression profiles in pre-eclampsia: evidence of increased miR-885-5p levels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BJOG (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/1471-0528.13903"}], "href": "https://doi.org/10.1111/1471-0528.13903"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26853698"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26853698"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Jordan L Plieskatt, Gabriel Rinaldi, Yanjun Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct miRNA signatures associate with subtypes of cholangiocarcinoma from infection with the tumourigenic liver fluke Opisthorchis viverrini."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hepatol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jhep.2014.05.035"}], "href": "https://doi.org/10.1016/j.jhep.2014.05.035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25017828"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25017828"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "C Mooney, P J McKiernan, R Raoof, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma microRNA levels in male and female children with cystic fibrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-020-57964-1"}], "href": "https://doi.org/10.1038/s41598-020-57964-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31980676"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31980676"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Xin Huang, Shujun Xu, Jie Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA expression profiling identifies DSPP regulators in cultured dental pulp cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2011.721"}], "href": "https://doi.org/10.3892/ijmm.2011.721"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21687927"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21687927"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Xiangdong Zhang, Huimin Gu, Li Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-885-3p is down-regulated in peripheral blood mononuclear cells from T1D patients and regulates the inflammatory response via targeting TLR4/NF-κB signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gene Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jgm.3145"}], "href": "https://doi.org/10.1002/jgm.3145"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31763742"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31763742"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Yuting Wang, Wen Zhang, Lin Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Oncol (Dordr) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13402-021-00610-3"}], "href": "https://doi.org/10.1007/s13402-021-00610-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34170484"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34170484"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Zhi Yang, Fan Zhang, Kai Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long Noncoding RNA HOXA-AS2 Facilitates Prostate Cancer Progression by Inhibiting miR-885-5p to Upregulate KDM5B."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Kidney Blood Press Res (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000527140"}], "href": "https://doi.org/10.1159/000527140"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36404720"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36404720"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Yan Li, Shenghan Lou, Jian Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "m"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "A methylation-mediated regulation of LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12967-024-04929-x"}], "href": "https://doi.org/10.1186/s12967-024-04929-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38281945"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38281945"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "RuiXue Yan, SaiTian Zeng, FangYuan Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircUBE2D2 regulates HMGB1 through miR-885-5p to promote ovarian cancer malignancy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clinics (Sao Paulo) (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.clinsp.2024.100391"}], "href": "https://doi.org/10.1016/j.clinsp.2024.100391"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38848634"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38848634"}]}]}]}
|
| Synonyms | MIRN885, HSA-MIR-885, MIR-885 |
| NCBI Gene ID | 100126334 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR885 has 292 functional associations with biological entities spanning 4 categories (molecular profile, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 13 datasets.
Click the + buttons to view associations for MIR885 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR885 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR885 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR885 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR885 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR885 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR885 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR885 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR885 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR885 from the GeneSigDB Published Gene Signatures dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR885 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR885 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR885 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR885 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |